CurifyLabs has secured Series A funding to expand its operations in the US, strengthen its supply chain and accelerate development of its platform for automated, personalised medicine manufacturing.

CurifyLabs has secured Series A funding to expand its operations in the US, strengthen its supply chain and accelerate development of its platform for automated, personalised…

CurifyLabs raised $14 million in Series A funding just 14 months after its last round, bringing total funding above $19 million. Here’s why the Finnish pharmacy compounding…

Finland's CurifyLabs has raised a $14m Series A to expand in the US, where pharmacies in 21 states use its 3D printers to make custom medicine doses.